4-hydroxyphenylethanol has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dewapriya, P; Himaya, SW; Kim, SK; Li, YX | 1 |
| Corona, G; Spencer, JP; Vauzour, D | 1 |
2 other study(ies) available for 4-hydroxyphenylethanol and Parkinson Disease
| Article | Year |
|---|---|
Tyrosol exerts a protective effect against dopaminergic neuronal cell death in in vitro model of Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Cell Death; Cell Line; Dopamine; Dopaminergic Neurons; Humans; Membrane Potential, Mitochondrial; Mice; Neuroprotective Agents; Parkinson Disease; Phenylethyl Alcohol; Reactive Oxygen Species; Tyrosine 3-Monooxygenase | 2013 |
Caffeic acid, tyrosol and p-coumaric acid are potent inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity.
Topics: Animals; Caffeic Acids; Cells, Cultured; Coumaric Acids; Dopamine; Flavonoids; Mice; Neurons; Neuroprotective Agents; Parkinson Disease; Phenylethyl Alcohol; Propionates; Wine | 2010 |